Toshifumi Hoki

560 citations
21 papers · 381 indexed · h-index 7
Topics
Immunotherapy and Immune Responses (8 papers)CAR-T cell therapy research (6 papers)Cancer Immunotherapy and Biomarkers (6 papers)

In The Last Decade

Toshifumi Hoki

18 papers receiving 377 citations

Peers

Toshifumi Hoki
Comparison fields: 5 of 56
  • Oncology 180
  • Immunology 147
  • Molecular Biology 92
  • Epidemiology 87
  • Cancer Research 53
Replace Sarah E. Fenton with:
Sarah E. Fenton United States
Yong Shao China
Donnele Daley United States
Daniel Tippens United States
Alejandro Torres-Hernandez United States
André Jefremow Germany
Atsuro Sugita Japan
Xiaoshun He China
Adi Egozi Israel
Qi Cai China
Toshifumi Hoki relative to Sarah E. Fenton United States Sarah E. Fenton's profile →
Citations per field
00.5×1.5×1.9×
Sarah E. Fenton · 1×
Citations per year

Countries citing papers authored by Toshifumi Hoki

Since Specialization
Citations

This map shows the geographic impact of Toshifumi Hoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshifumi Hoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshifumi Hoki more than expected).

Fields of papers citing papers by Toshifumi Hoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshifumi Hoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshifumi Hoki. The network helps show where Toshifumi Hoki may publish in the future.

Co-authorship network of co-authors of Toshifumi Hoki

This figure shows the co-authorship network connecting the top 25 collaborators of Toshifumi Hoki. A scholar is included among the top collaborators of Toshifumi Hoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshifumi Hoki. Toshifumi Hoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 102
4 18
5 27
6 55
7 1
8 24
9 2
10 4
11 52
12 3
13 0
14 1
15 80
16
[Bendamustine-rituximab therapy is effective for transformed follicular lymphoma with significant expression of p53].
1
17
[Chronic hepatitis C presenting with hepatic involvement by chronic lymphocytic leukemia responding to polyethylene glycol interferon-α-2b].
1
18 2
19
[Studies on visual prognosis and its relationship to immunological behaviors of peripheral leucocytes and lymphocytes in Behçet disease (author's transl)].
1
20
[Antibody formation after intracorneal sensitization].
2

About Toshifumi Hoki

Toshifumi Hoki is a scholar working on Immunology, Oncology and Ophthalmology, having authored 21 papers that have together received 381 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Immunology (147 citations), Oncology (180 citations) and Hepatology (36 citations). Toshifumi Hoki has collaborated with scholars based in Japan, United States and Malaysia. Frequent co-authors include Fumito Ito, Takayoshi Yamauchi, Takaaki Oba, Kristopher Attwood, Kunle Odunsi, Yutaka Kawano, Tomohiro Kubo, Masayoshi Kobune, Tsutomu Sato and Junji Kato. Their work appears in journals such as Nature Communications, The Journal of Immunology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026